PTC Therapeutics Inc. buy Truist Financial Co.
Start price
18.09.23
/
50%
€22.80
Target price
18.09.24
€42.12
Performance (%)
33.33%
Price
23.07.24
€30.60
Summary
This prediction is currently active. With a performance of 33.33% the BUY prediction by Truist_Financial_Co_ is a big success. This prediction currently runs until 18.09.24. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
PTC Therapeutics Inc. | -1.290% | -1.290% |
iShares Core DAX® | -0.612% | 0.567% |
iShares Nasdaq 100 | -3.018% | -3.205% |
iShares Nikkei 225® | -2.647% | 0.330% |
iShares S&P 500 | -1.932% | -1.126% |
Comments by Truist_Financial_Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target lowered by analysts at Truist Financial Co. from $60.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.60
16.08.23
16.08.23
€59.68
16.08.24
16.08.24
-18.58%
23.07.24
23.07.24